Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aorta

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 1, 2007, Pages

  Atkins, Kevin B ^a,d   Prezkop, Antoine ^a   Park, James L ^a   Saha, Jharna ^a   Duquaine, Damon ^a   Charron, Maureen J ^c   Olson, Ann Louise ^b   Brosius III, Frank C ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Hypertension; Myosin phosphatase

Indexed keywords

CALCIUM ION; DEOXYCORTICOSTERONE ACETATE; GLUCOSE TRANSPORTER 4; MYOFIBRILLAR PROTEIN PHOSPHATASE 1; MYOSIN PHOSPHATASE; PHOSPHORUS DERIVATIVE; PROTEIN DERIVATIVE; PROTEIN SUBUNIT; SEROTONIN AGONIST; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; HYPERTENSION; HYPOTHESIS; IMPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; UNINEPHRECTOMY; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BLOOD PRESSURE; GLUCOSE TRANSPORTER TYPE 4; HYPERTENSION; MALE; MICE; MICE, TRANSGENIC; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION;

EID: 34547111533     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00854.2006     Document Type: Article

References (35)

1. Atkins KB, Johns D, Watts S, Webb RC, Brosius FC 3rd. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. J Hypertens 19: 1581-1587, 2001.
2. Atkins KB, Northcott CA, Watts SW, Brosius FC. Effects of PPAR-γ ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. Am J Physiol Heart Circ Physiol 288: H235-H243, 2005.
3. Banz WJ, Abel MA, Zemel MB. Insulin regulation of vascular smooth muscle glucose transport in insulin-sensitive and resistant rats. Horm Metab Res 28: 271-275, 1996.
4. Bergandi L, Silvagno F, Russo I, Riganti C, Anfossi G, Aldieri E, Ghigo D, Trovati M, Bosia A. Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 2215-2221, 2003.
5. Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B, Roth BL. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gαq-coupled protein receptors. J Biol Chem 279: 34614-34623, 2004.
6. Booden MA, Siderovski DP, Der CJ. Leukemia-associated Rho guanine nucleotide exchange factor promotes Gαq-coupled activation of RhoA. Mol Cell Biol 22: 4053-4061, 2002.
7. Brosius FC 3rd, Briggs JP, Marcus RG, Barac-Nieto M, Charron MJ. Insulin-responsive glucose transporter expression in renal microvessels and glomeruli. Kidney Int 42: 1086-1092, 1992.
8. Bryant NJ, Govers R, James DE. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3: 267-277, 2002.
9. Chikumi H, Vazquez-Prado J, Servitja JM, Miyazaki H, Gutkind JS. Potent activation of RhoA by Gαq and Gq-coupled receptors. J Biol Chem 277: 27130-27134, 2002.
10. Christ G, Wingard C. Calcium sensitization as a pharmacological target in vascular smooth-muscle regulation. Curr Opin Investig Drugs 6: 920-933, 2005.
11. Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol 22: 1267-1272, 2002.
12. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274: 37385-37390, 1999.
13. 13 in agonist-induced vascular smooth muscle cell contraction. Circ Res 87: 221-227, 2000.
14. Hagen EC, Webb RC. Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats. Am J Physiol Heart Circ Physiol 247: H409-H414, 1984.
15. Hartshorne DJ. Myosin phosphatase: subunits and interactions. Acta Physiol Scand 164: 483-493, 1998.
16. Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 145: 727-740, 1999.
17. 2+-sensitivity in phasic and tonic smooth muscle. Verh K Acad Geneeskd Belg 54: 217-251, 1992.
18. Hirano K, Derkach DN, Hirano M, Nishimura J, Kanaide H. Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain. Mol Cell Biochem 248: 105-114, 2003.
19. 2+ sensitivity in vascular smooth muscle. J Smooth Muscle Res 40: 219-236, 2004.
20. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 259: 197-209, 2004.
21. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151-155, 1995.
22. Kawahara S, Umemoto S, Tanaka M, Umeji K, Matsuda S, Kubo M, Matsuzaki M. Up-regulation of Akt and eNOS induces vascular smooth muscle cell differentiation in hypertension in vivo. J Cardiovasc Pharmacol 45: 367-374, 2005.
23. Lee DL, Webb RC, Jin L. Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension 44: 796-799, 2004.
24. Marcus RG, England R, Nguyen K, Charron MJ, Briggs JP, Brosius FC III. Altered renal expression of the insulin-responsive glucose transporter GLUT4 in experimental diabetes mellitus. Am J Physiol Renal Fluid Electrolyte Physiol 267: F816-F824, 1994.
25. Matsumura Y, Kita S, Okui T. Mechanisms of endothelin-1-induced potentiation of noradrenaline response in rat mesenteric artery. Clin Exp Pharmacol Physiol 28: 540-544, 2001.
26. Mita S, Kobayashi N, Yoshida K, Nakano S, Matsuoka H. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. J Hypertens 23: 87-96, 2005.
27. 1 arrest and differentiation marker expression in vascular smooth muscle cells. Mol Pharmacol 58: 837-844, 2000.
28. Northcott CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res 91: 360-369, 2002.
29. Ohkawa Y, Hayashi K, Sobue K. Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. Biochem Biophys Res Commun 301: 78-83, 2003.
30. Olson AL, Liu ML, Moye-Rowley WS, Buse JB, Bell GI, Pessin JE. Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J Biol Chem 268: 9839-9846, 1993.
31. Park JL, Loberg RD, Duquaine D, Zhang H, Deo BK, Ardanaz N, Coyle J, Atkins KB, Schin M, Charron MJ, Kumagai AK, Pagano PJ, Brosius FC III. GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta. Arterioscler Thromb Vasc Biol 25: 1596-1602, 2005.
32. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411-418, 2003.
33. Vallejo J, Hardin CD. Metabolic organization in vascular smooth muscle: distribution and localization of caveolin-1 and phosphofructokinase. Am J Physiol Cell Physiol 286: C43-C54, 2004.
34. Vazquez-Prado J, Basile J, Gutkind JS. Modular architecture and novel protein-protein interactions regulating the RGS-containing Rho guanine nucleotide exchange factors. Methods Enzymol 390: 259-285, 2004.
35. Wehrwein EA, Northcott CA, Loberg RD, Watts SW. Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther 309: 1011-1019, 2004.